Zura Bio (ZURA) Climbs 3.25% as Phase II Milestones Hype Investor Optimism
Watch Zura Bio’s stock climb 3.25% amid clinical‑stage growth potential—see why investors eye Phase II milestones and market sentiment for a rebound.
3 minutes to read
ZURA BIO LTD